Print

Significant Dismissals Filed in April 2014

Case Number Plaintiff Defendant Document Date Patent #/Title Dismissal
1:12-cv-06781-RJS (Dkt. 82) Joao Control & Monitoring Systems LLC Digital Playground, Inc., et al. 4/10/2014

6,587,046 (“Monitoring apparatus and method”); 7,277,010 (same)

Discontinued with prejudice as to Digital Playground, Inc.
1:12-cv-02326-CM (Dkt. 250) Droplets, Inc E*Trade Financial Corporation, et al. 4/11/2014

6,687,745 (“System and method for delivering a graphical user interface of remote applications over a thing bandwidth connection”); 7,502,838 (“System and method for delivering remotely stored applications and information”)

Dismissed with prejudice as to Schwab defendants
1:13-cv-08033-KBF (Dkt. 16) Leighton Technologies LLC Ask, S.A., et al. 4/14/2014

5,817,207 (“Radio frequency identification card and hot lamination process for the manufacture of radio frequency identification cards”);
6,214,155 (same);
6,036,099 (“Hot lamination process for the manufacture of a combination contact/contactless smart card and product resulting therefrom”);
6,514,367 (same);
6,557,766 (Hot lamination method for a hybrid radio frequency optical memory card converting sheets into a web process”); RE40,145 (“Ultra-thin flexible durable radio frequency identification devices and hot or cold lamination process for the manufacture of ultra-thin flexible durable radio frequency identification devices”)

Discontinued without prejudice
1:13-cv-08037-KPF (Dkt. 20) Leighton Technologies LLC On Track Innovations, Ltd., et al. 4/14/2014

5,817,207 (“Radio frequency identification card and hot lamination process for the manufacture of radio frequency identification cards”);
6,214,155 (same);
6,036,099 (“Hot lamination process for the manufacture of a combination contact/contactless smart card and product resulting therefrom”);
6,514,367 (same);
6,557,766 (Hot lamination method for a hybrid radio frequency optical memory card converting sheets into a web process”); RE40,145 (“Ultra-thin flexible durable radio frequency identification devices and hot or cold lamination process for the manufacture of ultra-thin flexible durable radio frequency identification devices”)

Discontinued without prejudice
1:03-cv-08907-RJS (Dkt. 173) Affymetrix, Inc. Enzo Biochem, Inc., et al. 4/23/2014

4,707,440 (“Nucleic acid hybridization assay and detectable molecules useful in such assay”);
4,711,955 (Modified nucleotides and methods of preparing and using same”); 4,994,373 (“Method and structures employing chemically-labelled polynucleotide probes”);
5,175,269 (“Compound and detectable molecules having oligo- or polynucleotide with modifiable reactive group”);
5,241,060 (“Base moiety-labeled detectable nucleotide”);
5,328,824 (“Methods of using labeled nucleotides”);
5,449,767 (“Modified polynucleotides and methods of preparing same”); 5,476,928 (“Modified nucleotides and polynucleotides and complexes form therefrom”)

Dismissed with prejudice
1:10-cv-08197-PAE (Dkt. 91) Pfizer Inc. et al. Actavis Inc., et al. 4/23/2014 6,469,012 (“Pyrazolopyrimidinones for the treatment of impotence”) Stipulated dismissal without prejudice only as to Amneal Pharmaceuticals LLC
1:11-cv-09349-VSB (Dkt. 64) Loftex USA LLC Trident Limited (f/k/a Abhishek Industries Ltd.), et al. 4/23/2014 7,810,308 (“Method of producing a low twist towel”)

Dismissed with prejudice

1:12-cv-06973-RJS (Dkt. 252) Princeton Digital Image Corporation Facebook, Inc., et al. 4/25/2014 4,813,056 (“Modified statistical coding of digital signals”) Dismissed with prejudice
1:03-cv-08907-RJS (Dkt. 176) Affymetrix Enzo Biochem, et al. 4/25/2014

4,707,440 (“Nucleic acid hybridization assay and detectable molecules useful in such assay”);
4,711,955 (Modified nucleotides and methods of preparing and using same”); 4,994,373 (“Method and structures employing chemically-labelled polynucleotide probes”);
5,175,269 (“Compound and detectable molecules having oligo- or polynucleotide with modifiable reactive group”);
5,241,060 (“Base moiety-labeled detectable nucleotide”);
5,328,824 (“Methods of using labeled nucleotides”);
5,449,767 (“Modified polynucleotides and methods of preparing same”); 5,476,928 (“Modified nucleotides and polynucleotides and complexes form therefrom”)

Dismissed with prejudice
1:14-cv-02220-JSR (Dkt. 11) JDS Therapeutics, LLC et al. Church & Dwight, Co., Inc. 4/28/2014

5,948,772 (“Chromium picolinate compositions and uses thereof”);
6,143,301; (same)
6,136,317 (“Chromium picolinate compositions”)
6,251,889; (same) RE39,480 (“Chromium/biotin treatment of type II diabetes”)

Dismissed with prejudice
1:08-cv-10838-RJS (Dkt. 199) Gilead Sciences, Inc., et al. Teva Pharmaceuticals, Inc., et al. 4/30/2014

5,814,639 (“Method for synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds”);
5,914,331 (“Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane”);
6,642,245 (same); 6,703,396 (“Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers”)

Dismissed with prejudice

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.